Diplejía facial como presentación clínica del síndrome Guillain-Barré pos-COVID-19.

Introduction: During the COVID-19 pandemic, neurological manifestations affect at least 36% of patients. Cases of Guillain-Barré syndrome have been reported with coinfection by SARS-CoV-2 or with onset of symptoms days after infection by this agent. Objective: To describe a case of a patient with facial diplegia as a clinical form of postcovid-19 Guillain-Barré syndrome. Clinical case report: A 37-year-old female patient who in the first days of October 2021 had high respiratory condition with positive antigen test and polymerase chain reaction for COVID-19. Two weeks later, she began with paresthesias in her lower limbs and hands, difficulty speaking and closing both eyes. On neurological physical examination, she presented bilateral Bell's sign, effacement of the bilateral frontal and nasolabial furrows, deviation of the labial commissure to the right, and generalized areflexia. The nerve conduction study showed axonomyelinic damage of motor fibers of nerves explored bilaterally. The cerebrospinal fluid study was normal. Facial diplegia was considered as clinical presentation of post-covid-19 Guillain-Barré syndrome. She underwent treatment with immunoglobulin, vitamin therapy and rehabilitation, achieving her satisfactory clinical evolution. Conclusions: Facial diplegia is not the most frequent clinical form of Guillain-Barré syndrome, but it should alert to early diagnosis in patients with history of COVID-19. There is good clinical response after treatment with intravenous immunoglobulin. [ABSTRACT FROM AUTHOR]